News
U.S.-listed shares of Novo Nordisk plunged 7% in intraday trading Thursday after rival Eli Lilly reported positive oral ...
Jefferies analyst Benjamin Jackson CFA maintained a Sell rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...
Evotec’s cost-cutting drive has reached its pipeline. The company axed around 30% of its asset portfolio and offloaded ...
Rival companies trying to develop oral weight-loss candidates include Novo Nordisk, which has an oral formulation of ...
21h
Zacks Investment Research on MSNPharma Stock Roundup: J&J's Q1 Results, PFE's Obesity SetbackJ&J JNJ began the earnings season for the drug and biotech sector this week. Pfizer PFE announced the discontinuation of its ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novo Nordisk (NVO – Research Report) and ...
The chief executives of several pharmaceutical giants based in Ireland, such as Pfizer, Eli Lilly, and MSD, said there was a ...
Pharma companies are leveraging the United States’ threat of tariffs on drug imports to push for policy changes in the EU. | ...
Decarbonizing Health Care: Measuring the Carbon Footprint Impact of a National VA Telehealth Program
The U.S. Veterans Administration measures a substantial reduction in its carbon footprint associated with patient travel by ...
Arlington-based Texas Health Resources is suing six drugmakers and pharmacy benefit managers, alleging the parties colluded to drive up the price of insulin, according to court documents obtained by ...
Danish pharma major Novo Nordisk says that it has become aware of several hundred units of Ozempic (semaglutide) injection 1 mg distributed outside its authorized supply chain in the USA.
Danish drugmaker Novo Nordisk said several hundred counterfeit units of its diabetes drug Ozempic were being distributed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results